Eugenia Bloch‐Shilderman

418 total citations
25 papers, 336 citations indexed

About

Eugenia Bloch‐Shilderman is a scholar working on Plant Science, Insect Science and Molecular Biology. According to data from OpenAlex, Eugenia Bloch‐Shilderman has authored 25 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Plant Science, 10 papers in Insect Science and 9 papers in Molecular Biology. Recurrent topics in Eugenia Bloch‐Shilderman's work include Pesticide Exposure and Toxicity (15 papers), Insect and Pesticide Research (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Eugenia Bloch‐Shilderman is often cited by papers focused on Pesticide Exposure and Toxicity (15 papers), Insect and Pesticide Research (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Eugenia Bloch‐Shilderman collaborates with scholars based in Israel, United States and Germany. Eugenia Bloch‐Shilderman's co-authors include Philip Lazarovici, Victoria Trembovler, Esther Shohami, Eran Blaugrund, Ettie Grauer, I. Rabinovitz, Rachel Brandeis, Hao Jiang, Michal Linial and Aharon Levy and has published in prestigious journals such as FEBS Letters, Journal of Pharmacology and Experimental Therapeutics and Magnetic Resonance in Medicine.

In The Last Decade

Eugenia Bloch‐Shilderman

25 papers receiving 329 citations

Peers

Countries citing papers authored by Eugenia Bloch‐Shilderman

Since Specialization

Citations

This map shows the geographic impact of Eugenia Bloch‐Shilderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia Bloch‐Shilderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia Bloch‐Shilderman more than expected).

Fields of papers citing papers by Eugenia Bloch‐Shilderman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia Bloch‐Shilderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia Bloch‐Shilderman. The network helps show where Eugenia Bloch‐Shilderman may publish in the future.

Co-authorship network of co-authors of Eugenia Bloch‐Shilderman

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia Bloch‐Shilderman. A scholar is included among the top collaborators of Eugenia Bloch‐Shilderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia Bloch‐Shilderman. Eugenia Bloch‐Shilderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	“Catch-up" therapy: combining antidotal treatment with dermal application of AHA following percutaneous VX poisoning in the domestic swine 2023 ·Archives of Toxicology ·Eugenia Bloch‐Shilderman, (unknown), (unknown), (unknown), Nissan Ashkenazi	2
2	Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies 2021 ·International Journal of Pharmaceutics ·(unknown), (unknown), Eugenia Bloch‐Shilderman, (unknown), Nissan Ashkenazi	4
3	Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats 2019 ·Archives of Toxicology ·Eugenia Bloch‐Shilderman, (unknown), Liat Cohen, (unknown), Hila Gutman, (unknown), I. Rabinovitz, (unknown)	7
4	Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats 2017 ·Archives of Toxicology ·Eugenia Bloch‐Shilderman, I. Rabinovitz, (unknown), (unknown), Nahum Allon, (unknown)	7
5	Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes 2016 ·Toxicology and Applied Pharmacology ·Shlomi Lazar, (unknown), Rachel Brandeis, Shira Chapman, Eugenia Bloch‐Shilderman, Ettie Grauer	19
6	Synergism Between Anticholinergic and Oxime Treatments Against Sarin-Induced Ocular Insult in Rats 2015 ·Toxicological Sciences ·Ariel Gore, Rachel Brandeis, (unknown), J. Turetz, (unknown), Ettie Grauer, Eugenia Bloch‐Shilderman	8
7	Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin‐induced miosis and visual impairment in rats 2014 ·British Journal of Pharmacology ·Ariel Gore, Eugenia Bloch‐Shilderman, (unknown), J. Turetz, Rachel Brandeis	7
8	Efficacy Assessment of Various Anticholinergic Agents Against Topical Sarin-Induced Miosis and Visual Impairment in Rats 2012 ·Toxicological Sciences ·Ariel Gore, Rachel Brandeis, (unknown), (unknown), J. Turetz, Eugenia Bloch‐Shilderman	9
9	Early in vivo MR spectroscopy findings in organophosphate‐induced brain damage—potential biomarkers for short‐term survival 2012 ·Magnetic Resonance in Medicine ·Shai Shrot, (unknown), Amir Krivoy, (unknown), Yossi Rosman, Eugenia Bloch‐Shilderman, Shlomi Lazar, Amnon Bar‐Shir, Yoram Cohen	10
10	Deterioration in brain and heart functions following a single sub-lethal (0.8 LCt50) inhalation exposure of rats to sarin vapor: 2011 ·Toxicology and Applied Pharmacology ·Nahum Allon, Shira Chapman, (unknown), I. Rabinovitz, (unknown), B.A. Weissman, (unknown), Eugenia Bloch‐Shilderman, Ettie Grauer	18
11	Subchronic exposure to low-doses of the nerve agent VX: Physiological, behavioral, histopathological and neurochemical studies 2008 ·Toxicology and Applied Pharmacology ·Eugenia Bloch‐Shilderman, I. Rabinovitz, (unknown), Lily Raveh, Nahum Allon, Ettie Grauer, Eran Gilat, Ben Avi Weissman	15
12	Transient and reversible nephrotoxicity of sarin in rats 2006 ·Journal of Applied Toxicology ·Eugenia Bloch‐Shilderman, Aharon Levy	8
13	Subcellular Alterations of Protein Kinase C Isozymes in the Rat Brain after Organophosphate Poisoning 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Eugenia Bloch‐Shilderman, Tamar Kadar, Aharon Levy, Rita Sahar, I. Rabinovitz, Eran Gilat	9
14	Pardaxin Stimulation of Phospholipases A2 and Their Involvement in Exocytosis in PC-12 Cells 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Eugenia Bloch‐Shilderman, (unknown), Victoria Trembovler, (unknown), Arie Gruzman, Michal Linial, Philip Lazarovici	18
15	Pardaxin, an ionophore neurotoxin, induces PC12 cell death: activation of stress kinases and production of reactive oxygen species. 2002 ·PubMed ·Eugenia Bloch‐Shilderman, Hao Jiang, Philip Lazarovici	11
16	Involvement of Extracellular Signal-Regulated Kinase (ERK) in Pardaxin-Induced Dopamine Release from PC12 Cells 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Eugenia Bloch‐Shilderman, Hao Jiang, (unknown), Michal Linial, Philip Lazarovici	24
17	Rasagiline, a monoamine oxidase‐B inhibitor, protects NGF‐differentiated PC12 cells against oxygen‐glucose deprivation 1999 ·Journal of Neuroscience Research ·(unknown), Eran Blaugrund, Victoria Trembovler, Eugenia Bloch‐Shilderman, Esther Shohami, Philip Lazarovici	1
18	Characterization of Pardaxin-Induced Dopamine Release from Pheochromocytoma Cells: Role of Calcium and Eicosanoids 1999 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Eugenia Bloch‐Shilderman, Peter I. Lelkes, Victoria Trembovler, Esther Shohami, Yehuda Gutman, Philip Lazarovici	19
19	Isolation, characterization and synthesis of a novel pardaxin isoform 1998 ·FEBS Letters ·Knut Adermann, Manfred Raida, (unknown), (unknown), Eugenia Bloch‐Shilderman, Philip Lazarovici, Jacob Hochman, Hans H. Wellhöner	26
20	Pardaxin, a New Pharmacological Tool to Stimulate the Arachidonic Acid Cascade in PC12 Cells 1998 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Eugenia Bloch‐Shilderman, Esther Shohami, Victoria Trembovler, Yechiel Shai, Joseph Weidenfeld, Saul Yedgar, Yehuda Gutman, Philip Lazarovici	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact